To prevent, protect and save the ischemic heart: Antioxidants revisited

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 8, 2009, Pages 945-956

  Andreadou, Ioanna ^a,b   Iliodromitis, Efstathios K ^a   Farmakis, Dimitrios ^a   Kremastinos, Dimitrios Th ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Antioxidants; Atherosclerosis; Ischemia; Postconditioning; Preconditioning; Reactive oxygen species; Reperfusion

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATALASE; DEFEROXAMINE; DEHYDROASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE B; GLUTATHIONE PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; IRON CHELATING AGENT; ISONIAZID DERIVATIVE; JANUS KINASE 2; LOW DENSITY LIPOPROTEIN; OLEUROPEIN; OLIVE OIL; OMEGA 3 FATTY ACID; POLYPHENOL; PROPRANOLOL; RAMIPRIL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RESVERATROL; RETINOL; STAT1 PROTEIN; STAT3 PROTEIN; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE; UNINDEXED DRUG;

APOPTOSIS; ATHEROSCLEROSIS; DIET SUPPLEMENTATION; DNA STRAND BREAKAGE; ELECTRON SPIN RESONANCE; ENDOTHELIAL DYSFUNCTION; FAT INTAKE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; RED WINE; REPERFUSION INJURY; REVIEW;

ANIMALS; ANTIOXIDANTS; CARDIOTONIC AGENTS; HUMANS; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 69149086632     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220903039698     Document Type: Review

References (149)

1. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, Oxford University Press, 1998
2. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 2009;81:457-464
3. Rao PS, Cohen MV, Mueller HS. Production of free radicals and lipid peroxides in early experimental myocardial ischemia. J Mol Cell Cardiol 1983;15:713-716
4. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990;15:129-135 (Pubitemid 20186835)
5. Suzuki S, Kaneko M, Chapman DC, Dhalla NS. Alterations in cardiac contractile proteins due to oxygen free radicals. Biochim. Biophys Acta 1997;1074:95-100
6. Ceconi C, Cargnoni A, Pasini E, et al. Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol 1991;260:H1057-61
7. Schindler TH, Nitzche EU, Munzel T, et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. J Am Coll Cardiol 2003;42:814-822 (Pubitemid 37059738)
8. Minuz P, Fava C, Lechi A. Lipid peroxidation, isoprostanes and vascular damage. Pharmacol Rep 2006;58:57-68
9. Spiteller G. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis. Mol Nutr Food Res 2005;49:999-1013 (Pubitemid 41735561)
10. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 1988;4:5A-10A
11. Nicholson AC, Frieda S, Pearce A, Silverstein RL. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 1995;15:269-275
12. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924 (Pubitemid 19101597)
13. Mallat Z, Nakamura T, Ohan J, et al. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Investig 1999;103:421-427 (Pubitemid 29069993)
14. Galis ZS, Khatii JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-262
15. Ridker PM, Brown NJ, Vaughan DE, et al. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004;109(Suppl 1):IV6-19
16. Zalba G, Fortuño A, Orbe J, et al. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:587-593 (Pubitemid 46263404)
17. Simonet S, Porro de Bailiencourt J, Descombes JJ, et al. Hypoxia causes an abnormal contractile response in the atherosclerotic rabbit aorta. Implication of reduced nitric oxide and cGMP production. Circ Res 1993;72:616-630
18. Behr D, Rupin A, Fabiani JN, Verbeuren TJ. Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis 1999;142:335-344 (Pubitemid 29059492)
19. Wilcox JN, Subramanian RR, Sundell CL, et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 1997;17:2479-2488 (Pubitemid 28015984)
20. Luoma JS, Stralin P, Marklund SL, et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 1998;18:157-167 (Pubitemid 28277591)
21. Behr-Roussel D, Rupin A, Sansilvestri-Morel P, et al. Histochemical evidence for inducible nitric oxide synthase in advanced but non-ruptured human atherosclerotic carotid arteries. Histochem J 2000;32:41-51 (Pubitemid 30204155)
22. Maulik N, Sasaki H, Addya S, Das DK. Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors. FEBS Lett 2000;485:7-12 (Pubitemid 30844907)
23. Brune B, von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998;351:261-272 (Pubitemid 28321461)
24. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-175 (Pubitemid 36231924)
25. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363-368
26. Victor VM, Rocha M. Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases. Curr Pharm Des 2007;13:845-863 (Pubitemid 46585507)
27. Gonzalez MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003;115(Suppl 8A):99S-106S
28. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27-32
29. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000;47:446-456 (Pubitemid 30646067)
30. Ohta H, Adachi T, Hirano K. Internalization of human extracellular- superoxide dismutase by bovine aortic endothelial cells. Free Radic Biol Med 1994;16:501-507 (Pubitemid 24105998)
31. Steare SE, Yellon DMJ. The protective effect of heat stress against reperfusion arrhythmias in the rat. Mol Cell Cardiol 1993;25:1471-1481 (Pubitemid 24049455)
32. Keaney JF Jr, Simon DI, Freedman JE. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J 1999;13:965-975
33. Ness AR, Powles JW, Khaw KT. Vitamin C and cardiovascular disease: a systematic review. J Cardiovasc Risk 1996;3:513-521
34. Palace VP, Khaper N, Qin Q, Singal PK. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med 1999;26:746-761 (Pubitemid 29146279)
35. Kalaysioglu S, Sinci V, Imren Y, Oz E. Metoprolol prevents ischemia-reperfusion injury by reducing lipid peroxidation. Jpn Circ J 1999;63:718-721 (Pubitemid 29436668)
36. Khaper N, Rigatto C, Senevirante C, et al. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol 1997;29:3335-3344 (Pubitemid 28039367)
37. Jin ZQ, Chen X. Ramipril-induced delayed myocardial protection against free radical injury involves bradykinin B2 receptor-NO pathway and protein synthesis. Br J Pharmacol 1998;125:556-562 (Pubitemid 28451495)
38. Paraskevaidis IA, Iliodromitis EK, Vlahakos D, et al. Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance. Eur Heart J 2005;26:263-270 (Pubitemid 40227432)
39. Horackova M, Ponka P, Byczko Z. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H2O2 injury in adult cardiomyocytes. Cardiovasc Res 2000;47:529-536 (Pubitemid 30646074)
40. Davis N, Katz S, Wylie-Rosett J. The effect of diet on endothelial function. Cardiol Rev 2007;15:62-66
41. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr 2005;81:215S-7S
42. Du Y, Guo H, Lou H. Grape seed polyphenols protect cardiac cells from apoptosis via induction of endogenous antioxidant enzymes. J Agric Food Chem 2007;55:1695-1701 (Pubitemid 46479571)
43. Thirunavukkarasu M, Penumathsa SV, Samuel SM, et al. White wine induced cardioprotection against ischemia-reperfusion injury is mediated by life extending Akt/FOXO3a/NFκB survival pathway. J Agric Food Chem 2008;56:6733-6739
44. Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2007;2:133-138 (Pubitemid 46957321)
45. Andreadou I, Iliodromitis EK, Mikros E, et al. The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr 2006;136:2213-2219 (Pubitemid 44156827)
46. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456 (Pubitemid 23143847)
47. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:56-65 (Pubitemid 41002839)
48. Guaiquil VH, Golde DW, Beckles DL, et al. Vitamin C inhibits hypoxia-induced damage and apoptotic signaling pathways in cardiomyocytes and ischemic hearts. Free Radic Biol Med 2004;37:1419-1429
49. Garlic PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987;61:757-760
50. Grech ED, Dodd NJ, Jackson MJ, et al. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol 1996;77:122-127 (Pubitemid 26032596)
51. Slezak J, Tribulova N, Pristacova J, et al. Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol 1995;147:772-781
52. + -ATPase by hypochlorous acid. Am J Physiol 1998;275:C826-31
53. Musat S, Dhalla NS. Alteration in cardiac sarcolemmal ATP receptors by oxyradicals. Ann N Y Acad Sci 1996;793:1-12 (Pubitemid 26402581)
54. Tosaki A, Bagchi D, Pali T, et al. Comparisons of ESR and HPLC methods for the detection of OH. radicals in ischemic/reperfused hearts. A relationship between the genesis of free radicals and reperfusion arrhythmias. Biochem Pharmacol 1993;45:961-969
55. Cordis GA, Maulik N, Das DK. Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J Mol Cell Cardiol 1995;27:1645-1653
56. Cordis GA, Maulik G, Bagchi D, et al. Detection of oxidative DNA damage to ischemic reperfused rat hearts by 8-hydroxydeoxyguanosine formation. J Mol Cell Cardiol 1998;30:1939-1944 (Pubitemid 28495320)
57. Sato A, Sakuma I, Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 2003;285:H2345-54 (Pubitemid 37443050)
58. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. New Engl J Med 2007;357:1121-1135
59. de Jong JW, van der Meer P, Nieukoop AS, et al. Xanthine oxidoreductase activity in perfused hearts of various species, including humans. Circ Res 1990;67:770-773
60. Ungvari Z, Csiszar A, Edwards JG, et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-α, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003;13:418-424
61. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 2003;138:532-543 (Pubitemid 36315301)
62. Amsterdam EA, Pan HL, Rendig SV, et al. Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration. J Am Coll Cardiol 1993;22:1738-1744
63. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate. Arch Biochem Biophys 1993;300:535-543
64. Coudray C, Pucheu S, Boucher F, et al. Effect of ischemia/reperfusion sequence on cytosolic iron status and its release in the coronary effluent in isolated rat hearts. Biol Trace Elem Res 1994;41:69-75 (Pubitemid 24228270)
65. Van Jaarsveld H, Kuyl JM, Alberts DW. The protective effect of desferal on rat myocardial mitochondria is not prolonged after withdrawal of desferal. Basic Res Cardiol 1992;87:47-53
66. Dhalla NS, Panagia V, Singal PK, et al. Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol 1988;20:3-13 (Pubitemid 18131678)
67. Koppenol WH. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic Biol Med 1998;25:385-391
68. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995;268:L699-722
69. Lopez BL, Liu GL, Christopher TA, Ma XL. Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart. Coron Artery Dis 1997;8:149-153 (Pubitemid 27281078)
70. Ma XL, Lopez BL, Liu GL, et al. Peroxynitrite aggravates myocardial reperfusion injury in the isolated perfused rat heart. Cardiovasc Res 1997;36:195-204 (Pubitemid 27527344)
71. Jordan JE, Zhao ZQ, Vintent-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999;43:860-878 (Pubitemid 29413185)
72. Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 2007;20:1-22 (Pubitemid 46956808)
73. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 2004;61:372-385 (Pubitemid 38210145)
74. Takemura G, Fujiwara H. Role of apoptosis in remodeling after myocardial infarction. Pharmacol Ther 2004;104:1-16 (Pubitemid 39410559)
75. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 2007;115:1895-1903 (Pubitemid 46598903)
76. Downey JM, Cohen MV. Reducing infarct size in the setting of acute myocardial infarction. Progr Cardiovasc Dis 2006;48:363-371
77. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117:103-114
78. Hearse DJ, Humphrey SM, Chain EB. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 1973;5:395-407
79. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300
80. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 2003;35:339-341
81. + overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2006;290:H2024-34
82. + exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 2002;39:747-753
83. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006;70:181-190
84. Kramer JH, Arroyo CM, Dickens BF, Weglicki WB. Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production. Free Radic Biol Med 1987;3:153-159
85. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 1987;84(5):1404-1407
86. Chatham JC, Seymour AL, Harmsen E, Radda GK. Depletion of myocardial glutathione: its effects on heart function and metabolism during ischaemia and reperfusion. Cardiovasc Res 1988;22:833-839 (Pubitemid 18268713)
87. Pyles LA, Fortney JE, Kudlak JJ, et al. Plasma antioxidant depletion after cardiopulmonary bypass in operations for congenital heart disease. J Thorac Cardiovasc Surg 1995;110:165-171
88. Jolly SR, Kane WJ, Bailie MB, et al. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984;54:277-285
89. Ambrosio G, Becker LC, Hutchins GM, et al. Reduction in experimental infarct size by recombinant human superoxide dismoutase: insights into the pathophysiology of reperfusion injury. Circulation 1986;74:1424-1433 (Pubitemid 17189263)
90. Ambrosio G, Zweier JL, Jacobus WE, et al. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987;76:906-915 (Pubitemid 17151350)
91. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986;58:331-340
92. Manning A, Coltart DJ, Hearse DJ. Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res 1984;55:545-548
93. Andreadou I, Tasouli A, Iliodromitis E, et al. Reduction of myocardial infarct size in rabbits by a novel indole derivative with antioxidant and free radical scavenging properties. Eur J Pharmacol 2002;453:271-277 (Pubitemid 35223520)
94. Wang P, Chen H, Qin H, et al. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci USA 1998;95:4556-4560 (Pubitemid 28207951)
95. Sharp BR, Jones SP, Rimmer DM, Lefer DJ. Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am J Physiol Heart Circ Physiol 2002;282:H2422-6
96. +/- mouse hearts. Circulation 2002;105:981-986
97. Yoshida T, Maulik N, Engelman RM, et al. Targeted disruption of the mouse SOD I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res 2000;86:264-269 (Pubitemid 30108818)
98. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61:461-470 (Pubitemid 38210152)
99. Di Lisa F, Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006;70:191-199
100. Halestrap AP. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 2006;34:232-237
101. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136
102. Yellon DM, Alkulaif AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-277
103. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 1995;91:291-297
104. Kloner RA, Bolli R, Marban E, et al. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation 1998;97:1848-1867 (Pubitemid 28213629)
105. Sanada S, Kitakaze M. Ischemic preconditioning: emerging evidence, controversy, and translational trials. Int J Cardiol 2004;97:263-276 (Pubitemid 39286846)
106. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003;83:1113-1151
107. Oldenburg O, Qin Q, Krieg T, et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 2004;286:H468-76 (Pubitemid 38049514)
108. Eisen A, Fisman EZ, Rubenfire M, et al. Ischemic preconditioning: nearly two decades of research. A comprehensive review. Atherosclerosis 2004;172:201-210
109. Liu GS, Thornton J, Van Winkle DM, et al. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991;84:350-356
110. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-52 (Pubitemid 24121336)
111. Vegh A, Szekeres L, Parratt J. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 1992;107:648-652
112. Horimoto H, Gaudette CR, Krukenkamp IB. Nitric oxide is a requisite cofactor to generate adenosine triphosphate-sensitive potassium channel mediated preconditioning. Surg Forum 1998;49:202-203
113. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006;70:240-253
114. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol 2003;285:H579-88. Erratum in: Am J Physiol Heart Circ Physiol 2004 Jan; 286(1):H477
115. Kin H, Zatta AJ, Lofye MT, et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 2005;67:124-133 (Pubitemid 40798299)
116. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 2004;95:230-232
117. Yang XM, Philipp S, Downey JM, Cohen MV. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 2005100:57-63
118. Iliodromitis EK, Zoga A, Vrettou A, et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 2006;188:356-362 (Pubitemid 44313925)
119. Iliodromitis EK, Georgiadis M, Cohen MV, et al. Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res Cardiol 2006;101:502-507 (Pubitemid 44637866)
120. Cohen MV, Downey JM. Cardioprotection: spotlight on PKG. Br J Pharmacol 2007;152:833-834
121. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation 2005;112:2143-2148
122. Thibault H, Piot C, Staat P, et al. Long-term benefit of postconditioning. Circulation 2008;117:1037-1044
123. Iliodromitis EK, Paraskevaidis IA, Fountoulaki K, et al. Staccato reperfusion prevents reperfusion injury in patients undergoing coronary angioplasty: A 1-year follow-up pilot study. Atherosclerosis 2009;204(2):497-502
124. Tritto I, D'Andrea D, Eramo N, et al. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 1997;80:743-748 (Pubitemid 27181357)
125. Hess ML, Kukreja RC. Free radicals, calcium homeostasis, heat shock proteins, and myocardial stunning. Ann Thorac Surg 1995;60:760-766
126. Sun JZ, Tang XL, Park SW, et al. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Investig 1996;97:562-576
127. Ockaili R, Emani VR, Okubo S, et al. Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am J Physiol 1999;277(6 Pt 2):H2425-34 (Pubitemid 30048166)
128. Kukreja RC. Essential role of oxygen radicals in delayed pharmacological preconditioning. J Mol Cell Cardiol 2001;33:1395-1398
129. Gross GJ, Fryer RM. Sarcolemmal versus mitochondrial ATP-sensitive K + channels and myocardial preconditioning. Circ Res 1999;84:973-979
130. Schulz R, Cohen MV, Behrends M, et al. Signal transduction of ischemic preconditioning. Cardiovasc Res 2001;52:181-198
131. Cohen MV, Yang XM, Liu GS, et al. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial KATP channels. Circ Res 2001;89:273-278
132. Philipp S, Yang X-M, Cui L, et al. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 2006;70:308
133. Vinten-Johansen J. Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev 2007;12:235-244 (Pubitemid 350176696)
134. Lemasters JJ, Bond JM, Chacon E, et al. The pH paradox in ischemia-reperfusion injury to cardiac myocytes. EXS 1996;76:99-114
135. + channel and protein kinase C activation. Basic Res Cardiol 2006;101:180-189
136. Liu Y, Yang XM, Iliodromitis EK, et al. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res Cardiol 2008;103:54-59 (Pubitemid 50002795)
137. Kin H, Zhao ZQ, Sun HY, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004;62:74-85 (Pubitemid 38326813)
138. Halkos ME, Kerendi F, Corvera JS, et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 2004;78:961-969 (Pubitemid 39164812)
139. Mykytenko J, Kerendi F, Reeves JG, et al. Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Basic Res Cardiol 2007;102:90-100 (Pubitemid 44932774)
140. Skyschally A, Schulz R, Gres P, et al. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol 2003;284:H698-703 (Pubitemid 36142899)
141. Chen W, Gabel S, Steenbergen C, Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 1995;77:424-429
142. Pain T, Yang X, Critz SD, et al. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res 2000;15:460-466
143. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 2001;88:802-809 (Pubitemid 32429976)
144. Tanaka M, Fujiwara H, Yamasaki K, Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 1994;28:980-986 (Pubitemid 24232551)
145. Andreadou I, Iliodromitis EK, Mikros E, et al. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med 2004;37:500-510 (Pubitemid 38901082)
146. Andreadou I, Iliodromitis EK, Tsovolas K, et al. Acute administration of vitamin E triggers preconditioning via KATP channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radical Biol Med 2006;41:1092-1099 (Pubitemid 44348870)
147. Sbarouni E, Iliodromitis EK, Zoga A, et al. The effect of the phytoestrogen genistein on myocardial protection, preconditioning and oxidative stress. Cardiovasc Drugs Ther 2006;20:253-258 (Pubitemid 44701159)
148. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207-216 (Pubitemid 27129144)
149. Penna C, Mancardi D, Rastaldo R, et al. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 2007;75:168-177 (Pubitemid 46881061)